CRNX.NASDAQCrinetics Pharmaceuticals, INC
Form 4: Crinetics Pharmaceuticals CEO Reports Stock Transaction
Sentiment:
Insider Transaction (Form 4)
Richard Scott Struthers, President & CEO and a Director of Crinetics Pharmaceuticals, Inc., reported multiple transactions in common stock on September 1, 2026.
Summary
- Disposition to the issuer: disposed of 248,043 Common Stock at $85.00 ($21,083,655) on September 1, 2026; holds 176,663 after (Direct).
- Disposition to the issuer: disposed of 1,000 Common Stock at $85.00 ($85,000) on September 1, 2026 (Indirect).
- Disposition to the issuer: disposed of 136,805 Common Stock at $85.00 ($11,628,425) on September 1, 2026 (Indirect).
- Disposition to the issuer: disposed of 106,000 Common Stock at $85.00 ($9,010,000) on September 1, 2026 (Indirect).
- Disposition to the issuer: disposed of 110,000 Common Stock at $85.00 ($9,350,000) on September 1, 2026 (Indirect).
- Disposition to the issuer: disposed of 100,000 Common Stock at $85.00 ($8,500,000) on September 1, 2026 (Indirect).
- Disposition to the issuer: disposed of 111,100 Common Stock at $85.00 ($9,443,500) on September 1, 2026 (Indirect).
- Disposition to the issuer: disposed of 111,100 Common Stock at $85.00 ($9,443,500) on September 1, 2026 (Indirect).
- Disposition to the issuer: disposed of 111,100 Common Stock at $85.00 ($9,443,500) on September 1, 2026 (Indirect).
- Disposition to the issuer: disposed of 111,100 Common Stock at $85.00 ($9,443,500) on September 1, 2026 (Indirect).
- Disposition to the issuer: disposed of 80,000 Common Stock at $85.00 ($6,800,000) on September 1, 2026 (Indirect).
- Disposition to the issuer: disposed of 176,663 Common Stock at $85.00 ($15,016,355) on September 1, 2026 (Direct).
- Disposition to the issuer: disposed of 172,281 Stock Option (Right to Buy) at $59.81 ($10,304,127) on September 1, 2026 (Direct).
- Disposition to the issuer: disposed of 195,578 Stock Option (Right to Buy) at $62.39 ($12,202,111) on September 1, 2026 (Direct).
- Disposition to the issuer: disposed of 259,058 Stock Option (Right to Buy) at $69.71 ($18,058,933) on September 1, 2026 (Direct).
- Disposition to the issuer: disposed of 244,205 Stock Option (Right to Buy) at $64.98 ($15,868,441) on September 1, 2026 (Direct).
- Disposition to the issuer: disposed of 287,700 Stock Option (Right to Buy) at $65.36 ($18,804,072) on September 1, 2026 (Direct).
- Disposition to the issuer: disposed of 240,000 Stock Option (Right to Buy) at $41.49 ($9,957,600) on September 1, 2026 (Direct).
- Disposition to the issuer: disposed of 313,000 Stock Option (Right to Buy) at $48.14 ($15,067,820) on September 1, 2026 (Direct).
- Disposition to the issuer: disposed of 228,000 Stock Option (Right to Buy) at $41.21 ($9,395,880) on September 1, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Richard Scott Struthers — Director, Officer (President & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Disposition to the issuer | Common Stock | 248,043 | $85 | $21.1M | 176,663 |
| 2026-09-01 | Disposition to the issuer | Common Stock | 1,000 | $85 | $85.0K | 0 |
| 2026-09-01 | Disposition to the issuer | Common Stock | 136,805 | $85 | $11.6M | 0 |
| 2026-09-01 | Disposition to the issuer | Common Stock | 106,000 | $85 | $9.0M | 0 |
| 2026-09-01 | Disposition to the issuer | Common Stock | 110,000 | $85 | $9.3M | 0 |
| 2026-09-01 | Disposition to the issuer | Common Stock | 100,000 | $85 | $8.5M | 0 |
| 2026-09-01 | Disposition to the issuer | Common Stock | 111,100 | $85 | $9.4M | 0 |
| 2026-09-01 | Disposition to the issuer | Common Stock | 111,100 | $85 | $9.4M | 0 |
| 2026-09-01 | Disposition to the issuer | Common Stock | 111,100 | $85 | $9.4M | 0 |
| 2026-09-01 | Disposition to the issuer | Common Stock | 111,100 | $85 | $9.4M | 0 |
| 2026-09-01 | Disposition to the issuer | Common Stock | 80,000 | $85 | $6.8M | 0 |
| 2026-09-01 | Disposition to the issuer | Common Stock | 176,663 | $85 | $15.0M | 0 |
| 2026-09-01 | Disposition to the issuer | Stock Option (Right to Buy) | 172,281 | $60 | $10.3M | 0 |
| 2026-09-01 | Disposition to the issuer | Stock Option (Right to Buy) | 195,578 | $62 | $12.2M | 0 |
| 2026-09-01 | Disposition to the issuer | Stock Option (Right to Buy) | 259,058 | $70 | $18.1M | 0 |
| 2026-09-01 | Disposition to the issuer | Stock Option (Right to Buy) | 244,205 | $65 | $15.9M | 0 |
| 2026-09-01 | Disposition to the issuer | Stock Option (Right to Buy) | 287,700 | $65 | $18.8M | 0 |
| 2026-09-01 | Disposition to the issuer | Stock Option (Right to Buy) | 240,000 | $41 | $10.0M | 0 |
| 2026-09-01 | Disposition to the issuer | Stock Option (Right to Buy) | 313,000 | $48 | $15.1M | 0 |
| 2026-09-01 | Disposition to the issuer | Stock Option (Right to Buy) | 228,000 | $41 | $9.4M | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Disposition to the issuer (248,043 shares) |
| 2026-09-01 | Disposition to the issuer (1,000 shares) |
| 2026-09-01 | Disposition to the issuer (136,805 shares) |
| 2026-09-01 | Disposition to the issuer (106,000 shares) |
| 2026-09-01 | Disposition to the issuer (110,000 shares) |
| 2026-09-01 | Disposition to the issuer (100,000 shares) |
| 2026-09-01 | Disposition to the issuer (111,100 shares) |
| 2026-09-01 | Disposition to the issuer (111,100 shares) |
| 2026-09-01 | Disposition to the issuer (111,100 shares) |
| 2026-09-01 | Disposition to the issuer (111,100 shares) |
| 2026-09-01 | Disposition to the issuer (80,000 shares) |
| 2026-09-01 | Disposition to the issuer (176,663 shares) |
| 2026-09-01 | Disposition to the issuer (172,281 shares) |
| 2026-09-01 | Disposition to the issuer (195,578 shares) |
| 2026-09-01 | Disposition to the issuer (259,058 shares) |
| 2026-09-01 | Disposition to the issuer (244,205 shares) |
| 2026-09-01 | Disposition to the issuer (287,700 shares) |
| 2026-09-01 | Disposition to the issuer (240,000 shares) |
| 2026-09-01 | Disposition to the issuer (313,000 shares) |
| 2026-09-01 | Disposition to the issuer (228,000 shares) |
Keywords
insider transaction, Form 4, CRNX, Crinetics Pharmaceuticals, Inc., neutral, Richard Scott Struthers
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.